Tech Company Financing Transactions
Radiant Biotherapeutics Funding Round
Amplitude Ventures, Bill & Melinda Gates Foundation and Abrdn participated in a $35 million Series A capital raise for Radiant Biotherapeutics. The round was announced on 9/11/2024.
Transaction Overview
Company Name
Announced On
9/11/2024
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to further develop its lead clinical candidate, 4-1BB, and move it towards clinical trials.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
686 Bay Street, PGCRL 21.9430.X 21.9800 U1 E
Toronto, ON, M5G 0A4
Canada
Toronto, ON, M5G 0A4
Canada
Phone
Website
Email Address
Overview
Radiant is advancing a modular multi-valent and multi-specific platform built on breakthrough antibody engineering. Multabodies have demonstrated the potential to deliver potent multi-functional biologics to tackle difficult-to-treat diseases such as cancer, auto-immune and infectious diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Arthur Fratamico
Browse more venture capital transactions:
Prev: 9/11/2024: Datricks venture capital transaction
Next: 9/11/2024: Vind AI venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs